CASE REPORT article
Front. Oncol.
Sec. Head and Neck Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1621859
This article is part of the Research TopicEBV Strategies to Counteract the Immune ResponseView all 9 articles
EBV-positive small cell neuroendocrine carcinoma of the nasopharynx with cervical lymph node metastasis: a case report and literature review
Provisionally accepted
- Gansu Provincial Cancer Hospital, Lanzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Purpose: Investigating the diagnosis and treatment of Epstein-Barr virus-positive small cell neuroendocrine carcinomas of the nasopharynx with cervical lymph node metastasis. Methods: The clinical data of a patient with Epstein-Barr virus-positive small cell neuroendocrine carcinoma of the nasopharynx with cervical lymph node metastasis were retrospectively analyzed, and the relevant literature was reviewed. Case presentation: A 65-year-old female patient was admitted with a 1-day history of an incidentally discovered right cervical mass. Thyroid color Doppler ultrasonography revealed enlarged lymph nodes in regions II and Va of the right neck with loss of hilar structure (suspicious for metastasis). Magnetic resonance imaging demonstrated marked thickening of the bilateral nasopharyngeal walls and posterior-superior walls, with multiple enlarged lymph nodes in bilateral cervical level II regions (upper jugular chain), radiologically suggestive of metastatic involvement. Following comprehensive preoperative evaluation, the patient underwent concurrent ultrasound-guided core needle biopsy of cervical lymph nodes and endoscopic nasopharyngeal mass biopsy. The patient was pathologically diagnosed with Epstein-Barr virus-positive small cell neuroendocrine carcinoma of the nasopharynx with cervical lymph node metastasis. The patient received two cycles of etoposide-cisplatin induction chemotherapy and one cycle of targeted therapy (nimotuzumab) combined with radical radiotherapy(intensity-modulated radiation therapy, IMRT) to the nasopharyngeal and cervical lymph node regions. Follow-up magnetic resonance imaging demonstrated significant reduction in both the size of the nasopharyngeal tumor and the initially enlarged lymph nodes compared to previous scans. The patient remains on active anti-tumor therapy with ongoing clinical surveillance pending further longitudinal follow-up assessments. Conclusion: Epstein-Barr virus-positive nasopharyngeal small cell neuroendocrine carcinoma is an extremely rare head and neck malignancy. Identification of this rare tumor is crucial for disease management and patient prognosis.
Keywords: Epstein-Barr virus, Small cell neuroendocrine carcinoma, nasopharyngeal carcinoma, Treatment, case report
Received: 06 May 2025; Accepted: 20 Oct 2025.
Copyright: © 2025 Dong, Xue, Ma, Xudong, Wang, Wang, Li, Tian and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Fang Dong, doctordf@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.